Q3 2021 DBV Technologies SA Earnings Call Transcript
Welcome to the DBV Technologies conference call webcast. My name is Adrianne, and I'll be your operator for today's call. (Operator Instructions) Please note this conference is being recorded. I'll now turn the call over to Anne Pollak, Head of Investor Relations. Anne, you may begin.
Thank you. This afternoon, DBV Technologies issued a press release that outlines our financial results for the 3 and 9 months ended September 30, 2001 (sic) [2021] and regulatory updates. This release is available on the Press Release section of the DBV Technologies website.
Before we begin, please note that today's call may include a number of forward-looking statements, including but not limited to comments regarding our clinical and regulatory development plans; the timing and results of interactions with regulatory agencies; our forecast of our cash runway and the ability of any of our product candidates, if approved, to improve the lives of patients with food allergies. These forward-looking statements are based on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |